ONCOGENE CANCER RESEARCH

Registered charity 1206988 · accounts filings on the Charity Commission register

Our mission is to increase the life expectancy & quality of life for people with oncogene-driven lung cancers - like ALK, EGFR, RET, ROS1 and others. We empower patients with info, represent the patient voice & fundraise for medical research - all aimed at extending life expectancies and finding cures for these cancers. And finally, we provide grants and donations to research institutions.

Objects

THE PRESERVATION AND PROTECTION OF GOOD HEALTH BY;• SUPPORTING RESEARCH INTO THE NATURE, CAUSES, DIAGNOSIS, PREVENTION, TREATMENT AND CURE OF ONCOGENE-DRIVEN CANCERS SUCH AS ANAPLASTIC LYMPHOMA KINASE POSITIVE (ALK), EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), KRISTEN RAT SARCOMA (KRAS) AND OTHER ONCOGENE-DRIVEN CANCERS THAT TEND TO ORIGINATE IN THE LUNGS• SUPPORTING THOSE AFFECTED BY THESE CONDITIONS AND THEIR FAMILIES BY RAISING FUNDS AND WORKING WITH PHARMACEUTICAL COMPANIES, MEDICAL PROFESSIONALS, RESEARCHERS/RESEARCH BODIES, OTHER RELATED CHARITABLE TRUSTS AND ORGANISATIONS TO IMPROVE TREATMENT AND CARE OPTIONS AND TO MEET THE CHARITY’S OBJECTS

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Registered contact address: Kensington and Chelsea, London, England (from the postcode on the register)

Latest income
£59k
Latest spending
£624
Registered
2024
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity generated a surplus of £58,288 for the year ended 5 April 2025, with unrestricted net assets of the same amount. The filing notes that the charity is exempt from audit under the small companies regime and has no paid staff or fixed assets. Trustees were unpaid, and related party expenditures were not sought for repayment.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Largest income source: unclear
“Support came in many forms: friends ran the 2024 Paris Marathon, ran a 10k, took on a Tough Mudder, completed a Hyrox competition, dedicated birthday fundraisers, and donated wedding and inheritance gifts. A supporter secured a large gift from his employer, and our co-founders donated honoraria, while OCR received honoraria for advisory board participation. Passive donations from our supporters’ use of EasyFundraising also contributed.”
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Jan Clark and Yvonne Diaz incurred some expenditure on IT equipment, web domains and travel on behalf of the C I O and operate from home but are not seeking repayment and these sums are not accrued. No wages were paid in the period nor sought.
“Jan Clark and Yvonne Diaz incurred some expenditure on IT equipment, web domains and travel on behalf of the C I O and operate from home but are not seeking repayment and these sums are not accrued. No wages were paid in the period nor sought.” — page 23
Per its FY2025 accounts as filed with the Charity Commission.

Discloses 3 of 6 completeness components.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

From the charity’s annual return (Part A, self-declared)

Answers and figures the charity gave in Part A of its annual return to the Charity Commission. They are self-declared: not verified by the Commission or by this site. Only positive answers and figures are listed; items not listed are simply not shown.

Self-declared on the annual return for the financial year ending 05/04/2025

  • Volunteers: 8
  • Grant-making is its main activity

Source: this charity’s annual returns on the Charity Commission register.

Public fundraising profile: JustGiving — Oncogene Cancer Research (matched by registered charity number).

Funders the charity credits

Named as funders/supporters on the charity’s own website (the charity’s claim, distinct from accounts-verified grants).

Public profiles (found on the charity’s own website): facebook · instagram

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
05/04/2025£59k£624

Common questions

Is ONCOGENE CANCER RESEARCH financially healthy?

Per its FY2025 accounts: The accounts state that the charity generated a surplus of £58,288 for the year ended 5 April 2025, with unrestricted net assets of the same amount. The filing notes that the charity is exempt from audit under the small companies regime and has no paid staff or fixed assets. Trustees were unpaid, and related party expenditures were not sought for repayment.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with RESEARCH ALK+ UK.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
ONCOGENE CANCER RESEARCH£59k—0unclear—no doubt
RESEARCH ALK+ UK FY2025£34k—0unclear—no doubt
ALK POSITIVE LUNG CANCER (UK) FY2025£274k——unclear—no doubt
ABOVE & BEYOND CANCER FOUNDATION FY2025£82k—0unclear—no doubt
THE ORANGE FOUNDATION FY2025£60k——unclear—no doubt
FIGHTING ALL CANCERS TOGETHER FY2025£554k—0below—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.